Literature DB >> 12719023

Tuberculous pleural effusions.

Luis Valdés1, Antonio Pose, Esther San José, José Manuel Martínez Vázquez.   

Abstract

Tuberculosis is the most frequent cause of death due to infectious diseases. In Europe, it is one of the most frequent types of pleural effusions in young patients. Tuberculosis is caused by the rupture of a pulmonary subpleural caseous focus, which releases mycobacterium into the pleural cavity, thereby triggering an immune response involving mainly macrophages, CD4+ T lymphocytes, and the cytokines released by these cells (especially interleukin 1, interleukin 2, and ?-interferon). In recent years, classical microbiological and histological methods of diagnosis have been joined by biochemical analyses of pleural fluid, which are faster and can be more sensitive. In particular, tuberculous effusions have high adenosine deaminase (ADA) activity, apparently due to high levels of the ADA isoenzyme ADA2, which is only found in monocytes and macrophages (although certain data suggest the possible involvement of activated T cells, too). It has been recommended that treatment for tuberculosis be initiated if analysis of pleural fluid shows high ADA activity, a lymphocyte/neutrophil ratio greater than 0.75, and no malignant cells. Another highly efficient marker is ?-interferon, which is released by activated CD4+ T cells, but its high price is an obstacle to its routine determination in clinical practice. Identification of mycobacterial DNA by means of the polymerase chain reaction (PCR) is less efficient, apparently because its sensitivity depends heavily on mycobacterium concentration. No other biochemical parameters currently appear to be of marked relevance for the diagnosis of tuberculous pleural effusion (TPE). TPE responds well to the standard treatment for tuberculosis. However, 50% of TPE patients have a thickened pleura as a result of the accumulation of fluid, and in 16% the quantity of effusion increases during treatment, even if corticosteroids are administered. It therefore seems reasonable for treatment with antituberculous drugs to be preceded by therapeutic thoracocentesis to remove as much fluid as possible.

Entities:  

Year:  2003        PMID: 12719023     DOI: 10.1016/S0953-6205(03)00018-9

Source DB:  PubMed          Journal:  Eur J Intern Med        ISSN: 0953-6205            Impact factor:   4.487


  34 in total

1.  Macrophages are a source of extracellular adenosine deaminase-2 during inflammatory responses.

Authors:  B A Conlon; W R Law
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

Review 2.  Tuberculous pleural effusions: advances and controversies.

Authors:  Morné J Vorster; Brian W Allwood; Andreas H Diacon; Coenraad F N Koegelenberg
Journal:  J Thorac Dis       Date:  2015-06       Impact factor: 2.895

3.  High pleural ammonia negatively interferes with the measurement of adenosine deaminase activity.

Authors:  Tze Ping Loh; Karen Mei Ling Tan; Suru Chew; Douglas S G Chan
Journal:  BMJ Case Rep       Date:  2013-02-05

4.  Serum adenosine deaminase activity in patients with systemic lupus erythematosus: a study based on ADA1 and ADA2 isoenzymes pattern.

Authors:  Reza Saghiri; Niloufar Ghashghai; Shafieh Movaseghi; Pegah Poursharifi; Shohreh Jalilfar; Manijeh Ahmadi Bidhendi; Leila Ghazizadeh; Mina Ebrahimi-Rad
Journal:  Rheumatol Int       Date:  2011-02-25       Impact factor: 2.631

5.  Gamma interferon immunospot assay of pleural effusion mononuclear cells for diagnosis of tuberculous pleurisy.

Authors:  Mingfeng Liao; Qianting Yang; Jieyun Zhang; Mingxia Zhang; Qunyi Deng; Haiying Liu; Michael W Graner; Hardy Kornfeld; Boping Zhou; Xinchun Chen
Journal:  Clin Vaccine Immunol       Date:  2014-01-03

6.  Increased soluble and membrane-bound PD-L1 contributes to immune regulation and disease progression in patients with tuberculous pleural effusion.

Authors:  Xue Pan; Anyuan Zhong; Yufei Xing; Minhua Shi; Bin Qian; Tong Zhou; Yongjing Chen; Xueguang Zhang
Journal:  Exp Ther Med       Date:  2016-08-23       Impact factor: 2.447

7.  Increased pleural fluid adenosine deaminase levels in patients with malignant pleural effusions: a potential predictor of talc pleurodesis outcome.

Authors:  Huseyin Yildirim; Muzaffer Metintas; Güntülü Ak; Sinan Erginel; Fusun Alatas; Emel Kurt; Selma Metintas; Irfan Ucgun
Journal:  Lung       Date:  2007-10-19       Impact factor: 2.584

8.  Assessment of the N-PCR assay in diagnosis of pleural tuberculosis: detection of M. tuberculosis in pleural fluid and sputum collected in tandem.

Authors:  Parameet Kumar; Manas K Sen; Devendra S Chauhan; Vishwa M Katoch; Sarman Singh; Hanumanthappa K Prasad
Journal:  PLoS One       Date:  2010-04-19       Impact factor: 3.240

9.  Differential diagnosis of tuberculous and malignant pleural effusions: what is the role of adenosine deaminase?

Authors:  Bojan Zarić; Vesna Kuruc; Aleksandar Milovančev; Marica Markovic; Tatjana Šarčev; Vukašin Čanak; Slobodan Pavlović
Journal:  Lung       Date:  2008-03-21       Impact factor: 2.584

10.  Markers for differentiation of tubercular pleural effusion from non-tubercular effusion.

Authors:  Vivek Ambade; M M Arora; S P Rai; S K Nikumb; D R Basannar
Journal:  Med J Armed Forces India       Date:  2011-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.